miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction.
about
Identifying miRNA-mRNA regulation network of chronic pancreatitis based on the significant functional expressionMeclizine Preconditioning Protects the Kidney Against Ischemia-Reperfusion Injury.Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis.Vaspin regulates the osteogenic differentiation of MC3T3-E1 through the PI3K-Akt/miR-34c loopGeneration of kidney tubular organoids from human pluripotent stem cells.Cortical Morphogenesis during Embryonic Development Is Regulated by miR-34c and miR-204.Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathwaysDelivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo.Regulation of podocyte lesions in diabetic nephropathy via miR-34a in the Notch signaling pathwayMiR-34c-5p and CaMKII are involved in aldosterone-induced fibrosis in kidney collecting duct cells.Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.MicroRNAs associated with the development of kidney diseases in humans and animals.MicroRNA-148b regulates megalin expression and is associated with receptor downregulation in mice with unilateral ureteral obstruction.Therapeutic effects of serum extracellular vesicles in liver fibrosis.Decreased carbonyl reductase 1 expression promotes tumor growth via epithelial mesenchymal transition in uterine cervical squamous cell carcinomas.Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes.Cryptotanshinone hinders renal fibrosis and epithelial transdifferentiation in obstructive nephropathy by inhibiting TGF-β1/Smad3/integrin β1 signal.
P2860
Q33760457-B8820A00-BE01-420F-932D-9ADB6463B394Q36106304-278EAC3C-C1D3-4AA5-AC38-B56666D2D65DQ36339995-464C64E9-8DA0-41BC-98C7-EBCB2CFF2F53Q36882046-3032F314-C0DE-4F4F-AF2C-25C19FF1427DQ37508529-7346427A-12BD-4024-809F-AE94B43A97C1Q37633101-B25E7800-BAB2-42AF-B50C-BBF0A9D02359Q38851326-AADAE607-2985-4DB1-A881-A2469039BE87Q40775844-434AE0F0-DFFB-4B1D-AE94-B7AED9753A89Q41485250-2DAD785E-C133-4282-B5A7-A536B11AF49DQ47603517-AD118EC0-1120-49C4-BA9F-B3322B025BB5Q50063239-F615229F-54C1-42EC-B1C4-DB5BA57256A3Q50352301-54358E3A-3877-46B8-B86E-3549D357B5D5Q50781353-A465239F-8F50-4BE5-8FD4-7E0651675734Q54091049-85D65A37-E9F7-445A-AD46-716D9FE8EDB0Q55002082-041B7D67-64B1-4DA5-A247-E0BCCCB3A114Q55207759-F2EC9FC6-9E6E-432C-8735-7F061E7F8317Q55318062-24C9D224-E3E6-40B1-A2CF-47F35FDF1DA2
P2860
miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
miR-34c attenuates epithelial- ...... sis with ureteral obstruction.
@en
miR-34c attenuates epithelial- ...... sis with ureteral obstruction.
@nl
type
label
miR-34c attenuates epithelial- ...... sis with ureteral obstruction.
@en
miR-34c attenuates epithelial- ...... sis with ureteral obstruction.
@nl
prefLabel
miR-34c attenuates epithelial- ...... sis with ureteral obstruction.
@en
miR-34c attenuates epithelial- ...... sis with ureteral obstruction.
@nl
P2093
P2860
P356
P1433
P1476
miR-34c attenuates epithelial- ...... osis with ureteral obstruction
@en
P2093
Hiroshi Itoh
Ken Hiratsuka
Koichiro Homma
Ryuji Morizane
Shizuka Fujii
P2860
P2888
P356
10.1038/SREP04578
P407
P577
2014-04-03T00:00:00Z